MedPath
HSA Approval

MOLOXIN FILM-COATED TABLETS 400MG

SIN15579P

MOLOXIN FILM-COATED TABLETS 400MG

MOLOXIN FILM-COATED TABLETS 400MG

November 12, 2018

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

J01MA14

moxifloxacin

Manufacturer Information

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Krka, d.d., Novo mesto

Active Ingredients

Moxifloxacin Hydrochloride 436.3mg eqv. to Moxifloxacin

400.00mg

Moxifloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOLOXIN FILM-COATED TABLETS 400MG - HSA Approval | MedPath